{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:59:29Z","timestamp":1762430369656},"reference-count":40,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"unspecified","delay-in-days":4817,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychol. Med."],"published-print":{"date-parts":[[1996,5]]},"abstract":"<jats:title>Synopsis<\/jats:title><jats:p>We investigated serum creatine phosphokinase (CPK) and associated parkinsonic (SEPS) and dyskinetic (AIMS) movements in 32 hospital admitted acute catatonic patients. Thirty-two (<jats:italic>N<\/jats:italic> = 24 without neuroleptics on admission) catatonic patients were compared with 32 non-catatonic dyskinetic psychiatric patients, 32 non-catatonic non-dyskinetic psychiatric patients and 32 healthy controls. CPK was significantly higher (<jats:italic>p<\/jats:italic> = 0\u00b7015) in catatonics (mean 255\u00b775, s.d. \u00b1 226\u00b754) than in healthy controls (38\u00b76, \u00b1 27\u00b74) and non-catatonic non-dyskinetic psychiatric patients (57\u00b71, \u00b1 120\u00b78) whereas there was no significant difference between catatonics and non-catatonic dyskinetic psychiatric patients (453\u00b74, \u00b1 128\u00b75). There were significantly positive correlations between CPK and AIMS, as well as significantly negative correlations between CPK and SEPS, in all three groups. Our results suggest that increased serum CPK in catatonia may be related to occurrence of dyskinetic movements. Furthermore, we were able to distinguish a parkinsonic (low CPK, low AIMS, high SEPS) and a dyskinetic (high CPK, high AIMS, low SEPS) subtype in catatonia.<\/jats:p>","DOI":"10.1017\/s0033291700035625","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T13:37:42Z","timestamp":1247146662000},"page":"547-553","source":"Crossref","is-referenced-by-count":28,"title":["Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients"],"prefix":"10.1017","volume":"26","author":[{"given":"G.","family":"Northoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Wenke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pflug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"S0033291700035625_ref016","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770100069007"},{"key":"S0033291700035625_ref012","first-page":"1","article-title":"Catatonia: a treatable disorder occasionally recognized","volume":"13","author":"Fink","year":"1993","journal-title":"Directions in Psychiatry"},{"key":"S0033291700035625_ref006","first-page":"79","article-title":"The neuroleptic malignant syndrome","volume":"41","author":"Caroff","year":"1980","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0033291700035625_ref039","doi-asserted-by":"publisher","DOI":"10.1007\/BF01813829"},{"key":"S0033291700035625_ref023","volume-title":"Movement Disorders","author":"Lohr","year":"1987"},{"key":"S0033291700035625_ref017","volume-title":"Assessment Manual for Psychopharmacology. DHEW 76\u2013338","author":"Guy","year":"1976"},{"key":"S0033291700035625_ref036","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.149.9.1279"},{"key":"S0033291700035625_ref038","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"S0033291700035625_ref030","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.157.1.41"},{"key":"S0033291700035625_ref003","first-page":"1","article-title":"Basal ganglia thalamo cortical circuits","volume":"9","author":"Alexander","year":"1990","journal-title":"Progress in Brain Research"},{"key":"S0033291700035625_ref010","doi-asserted-by":"publisher","DOI":"10.1080\/00332747.1992.11024612"},{"key":"S0033291700035625_ref019","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1001864"},{"key":"S0033291700035625_ref005","volume-title":"Dementia praecox oder die Gruppe der Schizophrenien","author":"Bleuler","year":"1911"},{"key":"S0033291700035625_ref022","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","article-title":"Neuroleptic malignant syndrome","volume":"142","author":"Levenson","year":"1985","journal-title":"American Journal of Psychiatry"},{"key":"S0033291700035625_ref020","volume-title":"Die Katatonie","author":"Kahlbaum","year":"1874"},{"key":"S0033291700035625_ref002","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.150.1.110"},{"key":"S0033291700035625_ref007","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1176\/ajp.146.3.324","article-title":"Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome","volume":"146","author":"Castillo","year":"1989","journal-title":"American Journal of Psychiatry"},{"key":"S0033291700035625_ref031","first-page":"145","volume-title":"Endogenous Psychosis","author":"Northoff","year":"1995"},{"key":"S0033291700035625_ref013","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1990.tb06439.x"},{"key":"S0033291700035625_ref025","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1176\/ajp.143.11.1374","article-title":"Lethal catatonia","volume":"143","author":"Mann","year":"1986","journal-title":"American Journal of Psychiatry"},{"key":"S0033291700035625_ref001","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(87)90010-2"},{"key":"S0033291700035625_ref004","volume-title":"Manual of Mental Disorders, 3rd edn.","year":"1987"},{"key":"S0033291700035625_ref008","volume-title":"Clinical Neuropsychiatry","author":"Cummings","year":"1985"},{"key":"S0033291700035625_ref026","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.04200050005001"},{"key":"S0033291700035625_ref009","first-page":"954","article-title":"Catatonia","volume":"ii","year":"1986","journal-title":"Lancet"},{"key":"S0033291700035625_ref011","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770060086012"},{"key":"S0033291700035625_ref015","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.134.4.462-b"},{"key":"S0033291700035625_ref018","first-page":"385","article-title":"Akute lebensbedrohliche Katatonie","volume":"53","author":"H\u00e4fner","year":"1982","journal-title":"Nervenarzt"},{"key":"S0033291700035625_ref021","volume-title":"Lehrbuch der Psychiatrie","author":"Kraepelin","year":"1905"},{"key":"S0033291700035625_ref024","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.158.3.328"},{"key":"S0033291700035625_ref027","first-page":"54","volume-title":"Biology of the Major Psychoses","author":"Meltzer","year":"1975"},{"key":"S0033291700035625_ref028","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1176\/ajp.133.2.192","article-title":"Serum creatine phosphokinase in schizophrenia","volume":"133","author":"Meltzer","year":"1976","journal-title":"American Journal of Psychiatry"},{"key":"S0033291700035625_ref029","first-page":"186","article-title":"Lorazepam and catatonia","volume":"52","author":"Menza","year":"1991","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0033291700035625_ref032","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1962.10.3.799"},{"key":"S0033291700035625_ref033","first-page":"696","article-title":"An improved procedure for serum creatine phosphokinase determination","volume":"69","author":"Rosalki","year":"1967","journal-title":"Journal of Laboratory Clinical Medicine"},{"key":"S0033291700035625_ref034","first-page":"187","article-title":"A consideration of the mechanisms by which lorazepam might treat catatonia","volume":"52","author":"Rosebush","year":"1991","journal-title":"Journal of Clinical Psychiatry"},{"key":"S0033291700035625_ref037","first-page":"1","article-title":"Das neuroleptische maligne Syndrom","volume":"103","author":"Sczesni","year":"1991","journal-title":"Wiener Klinische Wochenschrift"},{"key":"S0033291700035625_ref040","first-page":"48","article-title":"Catatonia: a review of the behavioral neurologic syndrome","volume":"3","author":"Taylor","year":"1990","journal-title":"Neuropsychiatry, Neuropsychology and Behavioral Neurology"},{"key":"S0033291700035625_ref014","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)92669-6"},{"key":"S0033291700035625_ref035","first-page":"357","article-title":"Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam","volume":"51","author":"Rosebush","year":"1990","journal-title":"Journal of Clinical Psychiatry"}],"container-title":["Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0033291700035625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T21:50:10Z","timestamp":1557697810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0033291700035625\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,5]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1996,5]]}},"alternative-id":["S0033291700035625"],"URL":"https:\/\/doi.org\/10.1017\/s0033291700035625","relation":{},"ISSN":["0033-2917","1469-8978"],"issn-type":[{"value":"0033-2917","type":"print"},{"value":"1469-8978","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,5]]}}}